首页> 外文期刊>Journal of Cancer >Comparison of Clinical Characteristics and Survival after Surgery in Patients with Non-B and Non-C Hepatocellular Carcinoma and Hepatitis Virus-Related Hepatocellular Carcinoma
【24h】

Comparison of Clinical Characteristics and Survival after Surgery in Patients with Non-B and Non-C Hepatocellular Carcinoma and Hepatitis Virus-Related Hepatocellular Carcinoma

机译:非B和非C肝细胞癌及肝炎病毒相关肝细胞癌患者的临床特征和手术后生存率的比较

获取原文
           

摘要

Background and aims: We compared clinicopathologic data and long-term clinical outcomes among patients with non-B and non-C hepatocellular carcinoma (NBNC-HCC) who underwent curative resection (group A, n=129), those with hepatitis B virus-related HCC (group B, n=62) and those with hepatitis C virus-related HCC (group C, n=284). Methods: Clinicopathologic characteristics and cumulative overall survival (OS) and recurrence-free survival (RFS) after curative resection were compared among the three groups. Results: The proportion of patients with non-liver cirrhosis (LC) or diabetes mellitus in group A was significantly higher than that in group B or group C. The mean maximum tumor size in group A was significantly larger than that of group B or group C. Cumulative 3-year OS rates after resection were 76% in group A, 79% in group B and 72% in group C (A vs. B, P=0.638; A vs. C, P=0.090; B vs. C, P=0.091; overall significance, P=0.088). The corresponding RFS rates after resection were 38% in group A, 36% in group B and 36% in group C (A vs. B, P=0.528; A vs. C, P=0.281; B vs. C, P=0.944; overall significance, P=0.557). In subgroup analyses in patients with LC, in those without LC and in those who satisfied the Milan criteria, similar results were obtained, i.e., the difference among the three groups did not reach significance in terms of OS and RFS. Conclusion: Long-term clinical outcomes in patients NBNC-HCC after curative resection were comparable to those in patients with hepatitis virus-related HCC after curative resection.
机译:背景与目的:我们比较了接受根治性切除术(A组,n = 129)的非B和非C肝细胞癌(NBNC-HCC)患者,B型肝炎病毒患者的临床病理数据和长期临床结局。相关的HCC(B组,n = 62)和患有丙型肝炎病毒相关的HCC(C组,n = 284)。方法:比较三组患者根治性切除后的临床病理特征,累积总生存期(OS)和无复发生存期(RFS)。结果:A组非肝硬化或糖尿病患者的比例显着高于B组或C组。A组的平均最大肿瘤大小显着大于B组或B组C.切除后三年累计OS率为A组76%,B组79%,C组72%(A vs.B,P = 0.638; A vs.C,P = 0.090; B vs. C,P = 0.091;总体意义,P = 0.088)。切除后相应的RFS率在A组中为38%,在B组中为36%,在C组中为36%(A对B,P = 0.528; A对C,P = 0.281; B对C,P = 0.944;总体显着性,P = 0.557)。在LC患者,无LC患者和满足Milan标准的患者的亚组分析中,获得了相似的结果,即,三组之间的差异在OS和RFS方面均不显着。结论:NBNC-HCC根治性切除后的长期临床疗效与肝炎病毒相关性HCC根治性切除后的患者相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号